top of page

Nancy A. Dreyer, PhD, MPH, FISPE

Chief Scientific Officer Emerita, IQVIA Real World Solutions

Adjunct Professor of Epidemiology, UNC Chapel Hill

  • Real-world evidence generation using passive and primary data collection

  • Widely published, her work on regulatory use of RWE has been cited in recent guidelines from the FDA, EMA & NMPA on regulatory use of RWE

  • Diverse therapeutic areas and settings, including drugs, medical devices, elite sports injuries and occupational health

Profile overview

Areas of expertise

Education & Fellowships

Recent External Highlights

35+ years of experience in epidemiology and business including

  • IQVIA SVP and Chief Scientific Officer

  • Quintiles/Outcome Sciences Inc, SVP, Chief of Scientific Affairs

  • i3 Research/Ingenix, UnitedHealth Group, SVP

  • Epidemiology Resources, Inc. and the  New England Epidemiology Institute, CEO & Founder

  • Epidemiologic methods for comparative effectiveness and safety

  • Assessing the relevance and reliability of RWE

  • Regulatory use of RWE for label approval and expansion

  • Person-generated health data

  • Real-world data linkage

  • BA, Brandeis University

  • Master of Public Health, Epidemiology, University of North Carolina

  • PhD, Epidemiology, University of North Carolina

  • Fellow, International Society of Pharmacoepidemiology

  • Fellow, Drug Information Association

  • Adjunct Professor of Epidemiology, University of North Carolina School of Global Public Health, Chapel Hill, NC

  • Drug Information Association Science & Policy Advisory Council

  • Duke-Margolis Center for Health Policy Research Planning Board

  • Trustee, Brandeis University

Career Highlights

  • Build and sold 2 businesses and helped initiative merger of two public companies

  • Strong track record of collaboration, e.g., developed agile injury analytics for the NFL and NBA to promote player health; created a 13-country patient registry for avian influenza which identified a repurposed drug treatment that more than doubled the chance of survival 

  • Experienced in patient-reported health data and linked real-world data such as claims, electronic medical records; evidenced by work on COVID-19 ( and work with the European Medicines Agency (doi:10.2196/publichealth.4939)

  • Internationally recognized industry expert in the use of real-world evidence for regulatory purposes, influencing the content of recent guidelines by medical product regulators in the US (FDA), Europe (EMA), and China (NMPA)  

  • Environmental experience includes establishing context for risks from hazards including ionizing radiation, petrochemicals and electromagnetic fields and laying the scientific foundation for use in the successful reorganization of Manville in US Bankruptcy Court

Executive Highlights

  • CEO: Founded and led Epidemiology Resources Inc and the New England Epidemiology Institute; launched the peer-reviewed journal, Epidemiology; sold research firm and school to UnitedHealth and the journal to Williams and Wilkins 

  • SVP at UnitedHealth: led drug safety group and collaborated with its emerging CRO business

  • SVP and Global Chief of Scientific Affairs at Outcome Sciences: Built the scientific services and shaped the company for acquisition by Quintiles 

  • SVP and Chief Scientific Officer, IQVIA Real World Solutions, formerly Quintiles and IMS Health: Spearheaded the partnership of Quintiles and IMS Health, resulting in the merger of these public companies to form IQVIA (IQV)

  • 30+ years P&L experience 

  • Substantial revenue generation from large multi-national companies

  • Investor conference experience

  • Chief Scientific Advisor, Picnic Health

bottom of page